8-K//Current report
AN2 Therapeutics, Inc. 8-K
Accession 0000950170-25-070305
$ANTXCIK 0001880438operating
Filed
May 12, 8:00 PM ET
Accepted
May 13, 4:05 PM ET
Size
308.4 KB
Accession
0000950170-25-070305
Documents
- 8-Kantx-20250513.htmPrimary
8-K
- EX-99.1antx-ex99_1.htm
EX-99.1
- EX-101.SCHantx-20250513.xsd
XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0000950170-25-070305-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLantx-20250513_htm.xml
IDEA: XBRL DOCUMENT
Issuer
AN2 Therapeutics, Inc.
CIK 0001880438
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001880438
Filing Metadata
- Form type
- 8-K
- Filed
- May 12, 8:00 PM ET
- Accepted
- May 13, 4:05 PM ET
- Size
- 308.4 KB